Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
QuintilesIMS
Express Scripts
Citi
Colorcon
McKesson
Boehringer Ingelheim
Chubb
McKinsey

Generated: August 20, 2017

DrugPatentWatch Database Preview

PENAPAR-VK Drug Profile

« Back to Dashboard

What is the patent landscape for Penapar-vk, and what generic Penapar-vk alternatives are available?

Penapar-vk is a drug marketed by Parke Davis and is included in two NDAs.

The generic ingredient in PENAPAR-VK is penicillin v potassium. There are eighty-seven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

Summary for Tradename: PENAPAR-VK

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list18
Patent Applications: see list1,614
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PENAPAR-VK at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
PENAPAR-VK
penicillin v potassium
TABLET;ORAL062001-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
PENAPAR-VK
penicillin v potassium
FOR SOLUTION;ORAL062002-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
PENAPAR-VK
penicillin v potassium
TABLET;ORAL062001-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
PENAPAR-VK
penicillin v potassium
FOR SOLUTION;ORAL062002-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Novartis
Johnson and Johnson
Daiichi Sankyo
Cerilliant
Fuji
Medtronic
Chinese Patent Office
Teva
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot